Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1cd7029ec038fa78d4b371f9bf08e9e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2010-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e0d4e89652461c64798c767223183a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b193f5b12e6695faf2741521b32e2d41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e279e9734c5f57a763e2e356579d059c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ceabb20fbd81419fde1b42be79910dff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9face199ed0cf079f5a262b5f5a57ae8 |
publicationDate |
2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010324119-A1 |
titleOfInvention |
Reducing irf4, dusp22, or flj43663 polypeptide expression |
abstract |
This document relates to the activity of interferon regulatory factor 4 (IRF4) in T-cell lymphomas. For example, methods and materials involved in reducing the expression of an IRF4 polypeptide in T-cell lymphoma cells and identifying agents having the ability to reduce expression of an IRF4 polypeptide in T-cell lymphoma cells are provided. This document also relates to reducing DUSP22 or FLJ43663 polypeptide activity in T-cell lymphomas. For example, methods and materials involved in reducing the expression of DUSP22 polypeptides and/or FLJ43663 polypeptides in T-cell lymphoma cells and identifying agents having the ability to reduce expression of DUSP22 polypeptides and/or FLJ43663 polypeptides in T-cell lymphoma cells are provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017073065-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022066674-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111253490-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013022092-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013022092-A1 |
priorityDate |
2009-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |